Increased plasma levels of thioredoxin in patients with glucose intolerance

Internal Medicine

Volumn 44, Issue 11, 2005, Pages 1127-1132

  Miyamoto, Shinzo ^a   Kawano, Hiroaki ^a   Hokamaki, Jun ^a   Soejima, Hirofumi ^a   Kojima, Sunao ^a   Kudoh, Takashi ^a   Nagayoshi, Yasuhiro ^a   Sugiyama, Seigo ^a   Sakamoto, Tomohiro ^a   Yoshimura, Michihiro ^a   Nakamura, Hajime ^b   Yodoi, Junji ^c   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Coronary disease; Diabetes mellitus; Impaired glucose tolerance; Oxidative stress

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; GLUCOSE; GLYCERYL TRINITRATE; GLYCOSYLATED HEMOGLOBIN; THIOREDOXIN;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXIDATIVE STRESS; PATIENT MONITORING; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; RADIOGRAPHY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; RISK FACTORS; THIOREDOXIN;

EID: 33644840515     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.1127     Document Type: Article

References (35)

1. DECODE Study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621, 1999.
2. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is s risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924, 1999.
3. Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 267: C659-678, 1994 (Review).
4. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 46: S19-25, 1997.
5. Hawthorne GC, Bartlett K, Hetherington CS, Alberti KG. The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells. Diabetologia 32: 163-166, 1989.
6. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34: 146-154, 1999.
7. Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol 23: 885-891, 2003.
8. Polidori MC, Mecocci P, Stahl W, Sies H. Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 90: 147-150, 2003.
9. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
10. Nakamura H, De Rosa S, Roederer M, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8: 603-611, 1996.
11. Teshigawara K, Maeda M, Nishino K, et al. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol 2: 17-26, 1985.
12. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
13. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74: 955-963, 1986.
14. The expert committee on the diagnosis and classification of diabetes mellitus. Report of Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
15. Sakamoto T, Ogawa H, Kawano H, et al. Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost 83: 475-479, 2000.
16. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279: 30369-30374, 2004.
17. Miwa K, Kishimoto C, Nakamura H, et al. Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors. Circ J 69: 291-294, 2005.
18. Yudkin JS, Alberti KG, McLarty DG, Swai AB. Impaired glucose tolerance. BMJ 301: 397-402, 1990 (Review).
19. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500-1506, 1988.
20. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991 (Review).
21. Leinonen J, Lehtimaki T, Toyokuni S, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417: 150-152, 1997.
22. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. Diabetes Care 23: 1619-1629, 2000.
23. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359: 2072-2077, 2002.
24. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359: 2140-2144, 2002.
25. Miyamoto S, Sakamoto T, Soejima H, et al. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 146: 465-471, 2003.
26. Soejima H, Suefuji H, Miyamoto S, et al. Increased plasma thioredoxin in patients with acute myocardial infarction. Clin Cardiol 26: 583-587, 2003.
27. Hokamaki J, Kawano H, Soejima H, et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 99: 225-231, 2005.
28. Kostner K, Hornykewycz S, Yang P, et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 36: 330-336, 1997.
29. Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidative stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 102: 1007-1013, 2000.
30. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551, 1993.
31. Keaney JF Jr, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 38: 129-154, 1995.
32. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
33. Guzik TJ, West NE, Black E, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 86: E85-90, 2000.
34. Huraux C, Makita T, Kurz S, et al. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation 99: 53-59, 1999.
35. Walter MF, Jacob RF, Jeffers B, et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 44: 1996-2002, 2004.